{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T18:26:03Z","timestamp":1779215163692,"version":"3.51.4"},"reference-count":130,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Stichting Wetenschapsfonds Dystonie Vereniging, Prinses Beatrix Foundation, STW Technology Society"},{"DOI":"10.13039\/501100003142","name":"Fonds NutsOhra","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003142","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ipsen Pharmaceuticals"},{"name":"Allergan Pharmaceuticals"},{"name":"Medtronic and Actelion"},{"name":"Metakids and Ride4Life"},{"name":"Metabolic Power"},{"name":"Actelion"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience &amp; Biobehavioral Reviews"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.neubiorev.2016.03.015","type":"journal-article","created":{"date-parts":[[2016,4,10]],"date-time":"2016-04-10T10:26:55Z","timestamp":1460284015000},"page":"264-275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Serotonergic perturbations in dystonia disorders\u2014a systematic review"],"prefix":"10.1016","volume":"65","author":[{"given":"M.","family":"Smit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.L.","family":"Bartels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"van Faassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kuiper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.E.","family":"Niezen- Koning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.P.","family":"Kema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.A.","family":"Dierckx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.J.","family":"de Koning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Tijssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neubiorev.2016.03.015_bib0005","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ymgme.2005.09.007","article-title":"Aromatic l-aminoacid decarboxylase deficiency: unusual neonatal presentation and additional findings in organic acid analysis","volume":"87","author":"Abdenur","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0010","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1023\/A:1005307919767","article-title":"Aromatic l-amino acid decarboxylase deficiency: a new case with a mild clinical presentation and unexpected laboratory findings","volume":"21","author":"Abeling","year":"1998","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0015","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ymgme.2006.03.010","article-title":"Sepiapterin reductase deficiency an autosomal recessive DOPA-responsive dystonia","volume":"89","author":"Abeling","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0020","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/mds.25475","article-title":"Phenomenology and classification of dystonia: a consensus update","volume":"28","author":"Albanese","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0025","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1126\/science.1101678","article-title":"Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice","volume":"306","author":"Ansorge","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0030","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1177\/026988110201600418","article-title":"Acute dystonic reaction in an elderly patient with mood disorder after titration of paroxetine: possible mechanisms and implications for clinical care","volume":"16","author":"Arnone","year":"2002","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0035","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10048-011-0279-4","article-title":"Genotype-phenotype correlations in sepiapterin reductase deficiency: a splicing defect accounts for a new phenotypic variant","volume":"12","author":"Arrabal","year":"2011","journal-title":"Neurogenetics"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0040","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1203\/00006450-200207000-00017","article-title":"Selective decrease in central nervous system serotonin turnover in children with dopa-nonresponsive dystonia","volume":"52","author":"Assmann","year":"2002","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0045","doi-asserted-by":"crossref","first-page":"87re3","DOI":"10.1126\/scitranslmed.3002243","article-title":"Whole-genome sequencing for optimized patient management","volume":"3","author":"Bainbridge","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0050","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/ana.410440411","article-title":"Dopa-responsive dystonia: a clinical and molecular genetic study","volume":"44","author":"Bandmann","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0055","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/8904_2011_43","article-title":"Kinetic analyses guide the therapeutic decision in a novel form of moderate aromatic acid decarboxylase deficiency","volume":"3","author":"Barth","year":"2012","journal-title":"JIMD Rep."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0060","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00004583-199801000-00010","article-title":"Movement disorder with fluoxetine","volume":"37","author":"Bates","year":"1998","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0065","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1445-5994.2008.01747.x","article-title":"Persistent dystonia induced by fluoxetine","volume":"38","author":"Bilen","year":"2008","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0070","first-page":"327","article-title":"Acute dystonia and fluoxetine","volume":"53","author":"Black","year":"1992","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0075","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0022-3476(95)70458-2","article-title":"A missense mutation in a patient with guanosine triphosphate cyclohydrolase I deficiency missed in the newborn screening program","volume":"126","author":"Blau","year":"1995","journal-title":"J. Pediatr."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0080","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1023\/A:1005327313348","article-title":"Dihydropteridine reductase deficiency localized to the central nervous system","volume":"21","author":"Blau","year":"1998","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0085","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1023\/A:1005584627797","article-title":"Variant of dihydropteridine reductase deficiency without hyperphenylalaninaemia: effect of oral phenylalanine loading","volume":"22","author":"Blau","year":"1999","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0090","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1086\/321970","article-title":"Mutations in the sepiapterin reductase gene cause a novel tetrahydrobiopterin-dependent monoamine-neurotransmitter deficiency without hyperphenylalaninemia","volume":"69","author":"Bonafe","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0095","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/00004583-199904000-00003","article-title":"SSRIs and movement disorders","volume":"38","author":"Boyle","year":"1999","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0100","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/ana.410430417","article-title":"Cerebrospinal fluid homovanillic acid levels in rapid-onset dystonia-parkinsonism","volume":"43","author":"Brashear","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0105","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1126\/science.1083968","article-title":"Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene","volume":"301","author":"Caspi","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0110","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/cne.20377","article-title":"Epsilon-sarcoglycan immunoreactivity and mRNA expression in mouse brain","volume":"482","author":"Chan","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0115","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1177\/070674379504000723","article-title":"Fluvoxamine and mandibular dystonia","volume":"40","author":"Chong","year":"1995","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0120","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/brain\/awp084","article-title":"Exhaustive analysis of BH4 and dopamine biosynthesis genes in patients with dopa-responsive dystonia","volume":"132","author":"Clot","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0125","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1176\/ajp.152.1.122","article-title":"Fluoxetine and extrapyramidal side effects","volume":"152","author":"Coulter","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0130","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1176\/ajp.151.1.149a","article-title":"Fluoxetine-associated dystonia","volume":"151","author":"Dave","year":"1994","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.31887\/DCNS.2014.16.1\/adayer","article-title":"Serotonin-related pathways and developmental plasticity: relevance for psychiatric disorders","volume":"16","author":"Dayer","year":"2014","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0140","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1755-5949.2010.00135.x","article-title":"Role of serotonin in central dopamine dysfunction","volume":"16","author":"Di Giovanni","year":"2010","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0145","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1212\/WNL.0b013e3182452849","article-title":"Child neurology: paroxysmal stiffening, upward gaze, and hypotonia: hallmarks of sepiapterin reductase deficiency","volume":"78","author":"Dill","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0150","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.pediatrneurol.2006.05.006","article-title":"Sepiapterin reductase deficiency: clinical presentation and evaluation of long-term therapy","volume":"35","author":"Echenne","year":"2006","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0155","series-title":"Chemistry and Biology of Pteridines and Folates","first-page":"277","article-title":"Sepiapterin reductase deficiency: molecular analysis in a new case presenting with neurotransmitter deficiency without hyperphenylalaninemia","author":"Elzaouk","year":"2002"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0160","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/026988119701100114","article-title":"Behavioural effects of selective serotonin reuptake inhibitors following direct micro injection into the left red nucleus of the rat","volume":"11","author":"Faherty","year":"1997","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0165","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0014-2999(98)00041-7","article-title":"The functional sensitisation of sigma receptors following chronic selective serotonin reuptake inhibitor treatment","volume":"346","author":"Faherty","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0170","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ymgme.2006.10.013","article-title":"Molecular genetics of tetrahydrobiopterin (BH4) deficiency in the Maltese population","volume":"90","author":"Farrugia","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0175","first-page":"565","article-title":"Relief of benign essential blepharospasm and? memory loss by cyproheptadine","volume":"57","author":"Fasanella","year":"1993","journal-title":"Conn. Med."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0180","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10522-012-9406-3","article-title":"Serotonin: from top to bottom","volume":"14","author":"Fidalgo","year":"2013","journal-title":"Biogerontology"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0185","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1055\/s-2002-34497","article-title":"Aromatic l-amino acid decarboxylase deficiency with hyperdopaminuria. Clinical and laboratory findings in response to different therapies","volume":"33","author":"Fiumara","year":"2002","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0190","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1212\/01.wnl.0000247274.21261.b4","article-title":"Dopa-responsive hypersomnia and mixed movement disorder due to sepiapterin reductase deficiency","volume":"67","author":"Friedman","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0195","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/ana.22685","article-title":"Sepiapterin reductase deficiency: a treatable mimic of cerebral palsy","volume":"71","author":"Friedman","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0200","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00004714-199306000-00014","article-title":"Dystonic reaction associated with fluvoxamine","volume":"13","author":"George","year":"1993","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0205","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s100720070108","article-title":"Risperidone in idiopathic and symptomatic dystonia: preliminary experience","volume":"21","author":"Grassi","year":"2000","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0210","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.biopsych.2012.11.012","article-title":"Antidepressant treatment reduces serotonin-1A autoreceptor binding in major depressive disorder","volume":"74","author":"Gray","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0215","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/jmg.2008.061929","article-title":"Clinical and genetic delineation of neurodegeneration with brain iron accumulation","volume":"46","author":"Gregory","year":"2009","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0220","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4103\/0972-2327.132652","article-title":"Aromatic l-amino acid decarboxylase deficiency: a new case from Turkey with a novel mutation","volume":"17","author":"Gucuyener","year":"2014","journal-title":"Ann. Indian. Acad. Neurol."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0225","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.NMD.0000081667.02656.21","article-title":"High psychiatric comorbidity in spasmodic torticollis: a controlled study","volume":"191","author":"Gundel","year":"2003","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0230","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1136\/jnnp.2007.121699","article-title":"Psychiatric comorbidity in patients with spasmodic dysphonia: a controlled study","volume":"78","author":"Gundel","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0235","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/978-3-211-45295-0_72","article-title":"Pathophysiology of dystonia","volume":"70","author":"Hallett","year":"2006","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0240","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.earlhumdev.2012.12.012","article-title":"Infant developmental outcomes following prenatal exposure to antidepressants, and maternal depressed mood and positive affect","volume":"89","author":"Hanley","year":"2013","journal-title":"Early Hum. Dev."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0245","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1046\/j.1471-4159.1996.66062621.x","article-title":"Allelic variation of human serotonin transporter gene expression","volume":"66","author":"Heils","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0250","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/8904_2014_327","article-title":"Widening phenotypic spectrum of AADC deficiency, a disorder of dopamine and serotonin synthesis","volume":"17","author":"Helman","year":"2014","journal-title":"JIMD Rep."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0255","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neubiorev.2005.06.007","article-title":"Serotonergic modulation of the limbic system","volume":"30","author":"Hensler","year":"2006","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0260","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/070674379504000118","article-title":"An alert to extrapyramidal side-effects from SSRIs","volume":"40","author":"Hoaken","year":"1995","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0265","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJM198608073150602","article-title":"Brain neurotransmitters in dystonia musculorum deformans","volume":"315","author":"Hornykiewicz","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0270","first-page":"157","article-title":"Biochemical evidence for brain neurotransmitter changes in idiopathic torsion dystonia (dystonia musculorum deformans)","volume":"50","author":"Hornykiewicz","year":"1988","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0275","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1212\/WNL.42.10.1980","article-title":"Aromatic l-amino acid decarboxylase deficiency: clinical features, diagnosis, and treatment of a new inborn error of neurotransmitter amine synthesis","volume":"42","author":"Hyland","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0280","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/103985620801600101","article-title":"Remission of writer\u2019s cramp with sertraline","volume":"16","author":"Isaacs","year":"2008","journal-title":"Australas. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0285","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1620\/tjem.154.233","article-title":"Effect of tetrahydrobiopterin and 5-hydroxytryptophan on hereditary progressive dystonia with marked diurnal fluctuation: a suggestion of the serotonergic system involvement","volume":"154","author":"Ishida","year":"1988","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0290","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/ana.410230507","article-title":"Lesch-Nyhan syndrome: a study of motor behavior and cerebrospinal fluid neurotransmitters","volume":"23","author":"Jankovic","year":"1988","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0295","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/pch\/16.9.562","article-title":"Selective serotonin reuptake inhibitors in pregnancy and infant outcomes","volume":"16","author":"Jefferies","year":"2011","journal-title":"Paediatr. Child Health"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0300","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1097\/00004583-199609000-00006","article-title":"SSRI and EPS with fluoxetine","volume":"35","author":"Jones-Fearing","year":"1996","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0305","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jns.2006.10.010","article-title":"A study of CSF catecholamine and its metabolites in acute and convalescent period of encephalitis","volume":"252","author":"Kalita","year":"2007","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0310","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1600-0404.1985.tb03184.x","article-title":"5-Hydroxytryptamine in platelets of torsion dystonia patients","volume":"71","author":"Korczyn","year":"1985","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0315","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1474-4422(11)70141-7","article-title":"The monoamine neurotransmitter disorders: an expanding range of neurological syndromes","volume":"10","author":"Kurian","year":"2011","journal-title":"Lancet Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.neubiorev.2016.03.015_bib0320","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1007\/s10545-008-1009-4","article-title":"Sepiapterin reductase deficiency in a 2-year-old girl with incomplete response to treatment during short-term follow-up","volume":"32","author":"Kusmierska","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0325","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1002\/mds.23709","article-title":"Nonmotor manifestations of dystonia: a systematic review","volume":"26","author":"Kuyper","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0330","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0304-3940(98)00616-8","article-title":"Serotonergic modulation of eye blinks in cat and monkey","volume":"253","author":"LeDoux","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0335","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0361-9230(94)90197-X","article-title":"Inferior olive serotonin and norepinephrine levels during development in the genetically dystonic rat","volume":"33","author":"Ledoux","year":"1994","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0340","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1097\/00004583-199908000-00007","article-title":"Movement disorders associated with fluvoxamine","volume":"38","author":"Lenti","year":"1999","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0345","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1126\/science.274.5292.1527","article-title":"Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region","volume":"274","author":"Lesch","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0350","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/sleep\/33.3.307","article-title":"Sleep and rhythm consequences of a genetically induced loss of serotonin","volume":"33","author":"Leu- Semenescu","year":"2010","journal-title":"Sleep"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0355","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/00004714-199702000-00020","article-title":"Dystonia associated with trazodone and sertraline","volume":"17","author":"Lewis","year":"1997","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0360","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s004150050062","article-title":"Akathisia and acute dystonia induced by sumatriptan","volume":"244","author":"Lopez- Alemany","year":"1997","journal-title":"J. Neurol."},{"issue":"Suppl. 2","key":"10.1016\/j.neubiorev.2016.03.015_bib0365","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00004850-199210002-00003","article-title":"Serotonin and psychiatric disorders","volume":"7","author":"Lopez- Ibor","year":"1992","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0370","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0006-8993(09)90027-0","article-title":"Marked regional disturbances in brain metabolism of monoaminergic neurotransmitters in the genetically dystonic hamster","volume":"658","author":"Loscher","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0375","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/088307389701200602","article-title":"Aromatic l-amino acid decarboxylase deficiency: clinical features, diagnosis, and treatment of a second family","volume":"12","author":"Maller","year":"1997","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0380","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10545-009-1076-1","article-title":"Aromatic l-amino acid decarboxylase deficiency: clinical features, drug therapy and follow-up","volume":"32","author":"Manegold","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0385","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1017\/S003329170003960X","article-title":"The pathophysiology of extrapyramidal side-effects of neuroleptic drugs","volume":"10","author":"Marsden","year":"1980","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0390","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/1531-8257(199909)14:5<874::AID-MDS1028>3.0.CO;2-Q","article-title":"SSRI-induced reversal of levodopa benefit in two patients with dopa-responsive dystonia","volume":"14","author":"Mathen","year":"1999","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0395","doi-asserted-by":"crossref","DOI":"10.1007\/8904_2015_410","article-title":"Combined sepiapterin reductase and methylmalonyl-CoA epimerase deficiency in a second patient: cerebrospinal fluid polyunsaturated fatty acid level and follow-up under l-DOPA, 5-HTP and BH4 trials","author":"Mazzuca","year":"2015","journal-title":"JIMD Rep."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0400","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0091-3057(90)90053-K","article-title":"Enhanced sensitivity to quipazine in the genetically dystonic rat (dt)","volume":"37","author":"Michela","year":"1990","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0405","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fncir.2014.00021","article-title":"Interaction between the 5-HT system and the basal ganglia: functional implication and therapeutic perspective in Parkinson's disease","volume":"8","author":"Miguelez","year":"2014","journal-title":"Front. Neural Circuits"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0410","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/01616412.1988.11739843","article-title":"Spasmodic torticollis-like posture and caudate nucleus monoamine in cats: in vivo dialysis study","volume":"10","author":"Miyake","year":"1988","journal-title":"Neurol. Res."},{"issue":"264\u20139","key":"10.1016\/j.neubiorev.2016.03.015_bib0415","first-page":"W64","article-title":"Preferred reporting items for systematic reviews and meta- analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0420","doi-asserted-by":"crossref","first-page":"36425","DOI":"10.5539\/gjhs.v6n6p295","article-title":"Acute dystonia due to citalopram treatment: a case series","volume":"6","author":"Moosavi","year":"2014","journal-title":"Glob. J. Health. Sci."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0425","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/da.10039","article-title":"Relation between depression and anxiety in dystonic patients: implications for clinical management","volume":"16","author":"Moraru","year":"2002","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0430","first-page":"247","article-title":"Adolescent angst or true intent? Suicidal behavior, risk, and neurobiological mechanisms in depressed children and teenagers taking antidepressants","volume":"16","author":"Morrison","year":"2014","journal-title":"Int. J. Emerg. Ment. Health"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0435","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00004583-200401000-00008","article-title":"Citalopram and dystonia","volume":"43","author":"Najjar","year":"2004","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0440","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/BF01291793","article-title":"Neurotransmitters in CSF of idiopathic adult-onset dystonia: reduced 5-HIAA levels as evidence of impaired serotonergic metabolism","volume":"103","author":"Naumann","year":"1996","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0445","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1146\/annurev-neuro-071013-013916","article-title":"Reassessing models of basal ganglia function and dysfunction","volume":"37","author":"Nelson","year":"2014","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0450","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1093\/brain\/awh603","article-title":"Sepiapterin reductase deficiency: a congenital dopa-responsive motor and cognitive disorder","volume":"128","author":"Neville","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0455","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1248\/bpb.b13-00310","article-title":"Pathophysiological roles of serotonergic system in regulating extrapyramidal motor functions","volume":"36","author":"Ohno","year":"2013","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0460","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1046\/j.1468-2982.1998.1806358-4.x","article-title":"Sumatriptan-induced axial dystonia in a patient with cluster headache","volume":"18","author":"Oterino","year":"1998","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0465","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000091840","article-title":"Oculogyric dystonic reaction to escitalopram with features of anaphylaxis including response to epinephrine","volume":"140","author":"Patel","year":"2006","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0470","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1345\/aph.1P332","article-title":"Ondansetron-induced dystonia, hypoglycemia, and seizures in a child","volume":"45","author":"Patel","year":"2011","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0475","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/brain\/aws308","article-title":"SGCE mutations cause psychiatric disorders: clinical and genetic characterization","volume":"136","author":"Peall","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0480","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/01.smj.0000172786.09545.b5","article-title":"Dysphonia induced by selective serotonin reuptake inhibitors","volume":"98","author":"Petitpain","year":"2005","journal-title":"South. Med. J."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0485","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4038\/cmj.v59i1.5527","article-title":"Mosapride (5HT4 agonist) in the treatment of blepharospasm","volume":"59","author":"Piyasena","year":"2014","journal-title":"Ceylon Med. J."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0490","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/mds.870120650","article-title":"Successful treatment of fluoxetine-induced dystonia with low-dose mianserin","volume":"12","author":"Poyurovsky","year":"1997","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0495","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/mds.25532","article-title":"Emerging concepts in the physiological basis of dystonia","volume":"28","author":"Quartarone","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0500","first-page":"487","article-title":"Acute dystonia and fluoxetine","volume":"51","author":"Reccoppa","year":"1990","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0505","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/0091-3057(95)00162-P","article-title":"Behavioural response to pharmacologic manipulation of serotonin receptors in the genetically dystonic hamster","volume":"52","author":"Richter","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0510","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMoa1207281","article-title":"Brain dopamine- serotonin vesicular transport disease and its treatment","volume":"368","author":"Rilstone","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0515","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/10401239409148985","article-title":"Multiple serotonin receptors: clinical and experimental aspects","volume":"6","author":"Roth","year":"1994","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0520","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.braindev.2013.04.003","article-title":"Early replacement therapy in a first Japanese case with autosomal recessive guanosine triphosphate cyclohydrolase I deficiency with a novel point mutation","volume":"36","author":"Sato","year":"2014","journal-title":"Brain Dev."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0525","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/00005053-199511000-00010","article-title":"Fluoxetine for blepharospasm: interaction of serotonin and dopamine","volume":"183","author":"Schreiber","year":"1995","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0530","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.braindev.2010.10.015","article-title":"Hereditary progressive dystonia with marked diurnal fluctuation","volume":"33","author":"Segawa","year":"2011","journal-title":"Brain Dev."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0535","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1176\/ajp.151.2.288b","article-title":"Sertraline and extrapyramidal side effects","volume":"151","author":"Shihabuddin","year":"1994","journal-title":"Am. J. Psychiatry"},{"issue":"January (1)","key":"10.1016\/j.neubiorev.2016.03.015_bib0540","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1176\/appi.ajp.163.1.8","article-title":"SERT-ainly involved in depression, but when?","volume":"163","author":"Sibille","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0545","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.35.6.907","article-title":"Lesch-Nyhan syndrome: CSF neurotransmitter abnormalities","volume":"35","author":"Silverstein","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0550","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.earlhumdev.2012.08.001","article-title":"Neurobehavioral assessment of infants born at term and in utero exposure to serotonin reuptake inhibitors","volume":"89","author":"Smith","year":"2013","journal-title":"Early Hum. Dev."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0555","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10048-004-0182-3","article-title":"Heterozygous mutation in 5\u2032-untranslated region of sepiapterin reductase gene (SPR) in a patient with dopa-responsive dystonia","volume":"5","author":"Steinberger","year":"2004","journal-title":"Neurogenetics"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0560","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pediatrneurol.2014.09.015","article-title":"The expanding spectrum of neurological phenotypes in children with ATP1A3 mutations, alternating hemiplegia of childhood, rapid-onset dystonia-parkinsonism, CAPOS and beyond","volume":"52","author":"Sweney","year":"2015","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0565","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1212\/WNL.53.6.1205","article-title":"Clinical and therapeutic observations in aromatic l-amino acid decarboxylase deficiency","volume":"53","author":"Swoboda","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0570","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ymgme.2007.04.006","article-title":"Unusually mild phenotype of AADC deficiency in 2 siblings","volume":"91","author":"Tay","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0575","doi-asserted-by":"crossref","first-page":"532","DOI":"10.4103\/0253-7613.117760","article-title":"Fluvoxamine induced oculogyric dystonia and manic switch in a patient with obsessive compulsive disorder","volume":"45","author":"Tikka","year":"2013","journal-title":"Indian. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0580","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/jnnp.2004.051664","article-title":"Expanded motor and psychiatric phenotype in autosomal dominant Segawa syndrome due to GTP cyclohydrolase deficiency","volume":"77","author":"Van Hove","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0585","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0278-5846(02)00338-X","article-title":"Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review","volume":"27","author":"Vaswani","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0590","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ymgme.2008.04.003","article-title":"Two Greek siblings with sepiapterin reductase deficiency","volume":"94","author":"Verbeek","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0595","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/jnnp-2011-301714","article-title":"Deep brain stimulation for dystonia","volume":"84","author":"Vidailhet","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0600","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s00259-010-1663-2","article-title":"Measuring serotonin synthesis: from conventional methods to PET tracers and their (pre)clinical implications","volume":"38","author":"Visser","year":"2011","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0605","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/mds.23032","article-title":"Sepiapterin reductase deficiency: two Indian siblings with unusual clinical features","volume":"25","author":"Wali","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0610","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1176\/appi.ps.53.11.1477","article-title":"Sertraline-induced akathisia and dystonia misinterpreted as a panic attack","volume":"53","author":"Walker","year":"2002","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0615","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1111\/j.1460-9568.2011.07621.x","article-title":"Serotonin innervation of human basal ganglia","volume":"33","author":"Wallman","year":"2011","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0620","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0361-9230(91)90185-M","article-title":"Altered behavioral responses mediated by serotonin receptors in the genetically dystonic (dt) rat","volume":"26","author":"Wieland","year":"1991","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0625","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1212\/WNL.30.6.645","article-title":"Neurochemical analysis of cerebrospinal fluid","volume":"30","author":"Wood","year":"1980","journal-title":"Neurology"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0630","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/BF02335509","article-title":"Consideration on two cases of dystonia-parkinsonism","volume":"12","author":"Zambrino","year":"1991","journal-title":"Ital. J. Neurol. Sci."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0635","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0140-6736(96)90257-3","article-title":"Efficacy of risperidone in idiopathic segmental dystonia","volume":"347","author":"Zuddas","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0640","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/mds.25501","article-title":"Psychiatric comorbidities in dystonia: emerging concepts","volume":"28","author":"Zurowski","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0645","doi-asserted-by":"crossref","first-page":"e64654","DOI":"10.1371\/journal.pone.0064654","article-title":"Early neurological outcome of young infants exposed to selective serotonin reuptake inhibitors during pregnancy: results from the observational SMOK study","volume":"8","author":"de Vries","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neubiorev.2016.03.015_bib0650","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1136\/jnnp-2011-301386","article-title":"Cognition and psychopathology in myoclonus-dystonia","volume":"83","author":"van Tricht","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"}],"container-title":["Neuroscience &amp; Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763415301524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763415301524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T07:12:59Z","timestamp":1668582779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763415301524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":130,"alternative-id":["S0149763415301524"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2016.03.015","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serotonergic perturbations in dystonia disorders\u2014a systematic review","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2016.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}